AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 NOV 6 - (NewsRx.com & NewsRx.net) -- HPV DNA testing has a role in predicting cervical intraepithelial lesions.
According to recent research from the United States, "Human papillomavirus (HPV) is widely accepted as the primary agent involved in the development of squamous intraepithelial neoplasia and cervical carcinoma. Several commercial tests a re available for detecting HPV DNA.
"This study compares the efficacy of INFORMHPV (in situ hybridization [ISH] HPV) and HCII (HC HPV) in predicting cervical lesions. A total of 762 sequential Papanicolaou (Pap) smears determined by cytologic examination to be either atypical squamous cells of undetermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) were tested by both Hybrid Capture (HC) HPV and ISH HPV; 250 follow-up biopsies were reviewed as the reference standard for presence or absence of a lesion," wrote M.N. Qureshi and colleagues, Bayonne Medical Center.
"ISH HPV and HC HPV differed significantly in accurately predicting biopsy findings from ASC-US and LSIL cases. The overall sensitivity and specificity of ISH HPV were 97% (28129) and 86% (191/221); and HC HPV was 79% (23/29) and 56% (123/221)," the researchers wrote.
"The positive predictive value (PPV) of ISH HPV was 48% (28/158) vs. HC HPV value of 19% (23/121). Negative predictive value (NPV) was ...
Source: HighBeam Research, HPV DNA testing has a role in predicting cervical intraepithelial...